BioCardia Inc. (BCDA)
BioCardia Max Pain By Strike
BCDA trades at $1.9, 72.9% below the near-term max pain of $7 expiring Jan 16, 2026 (150 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is stable across expirations ($7-$83.33), indicating stable market expectations. High dispersion in max pain levels suggests competing forces and potential volatility.
BioCardia Max Pain By Expiry
Max pain for BCDA shows stable levels around 45.16, reflecting balanced market expectations. The 169% spread signals divergent expectations across timeframes. Most levels above 1.9 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Jan 16, 2026 | 7 | 5.10 (268.42%) |
| Jan 1, 2031 | 83.33 | 81.43 (4285.79%) |